NAT UNIV CORP MIE UNIV has a total of 11 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, medical technology and environmental technology are KARDIOLOG N TS AMN SSSR V, SCOTT & WHITE HEALTHCARE and ORTHOGEN GENTECHNOLOGIE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Pharmaceuticals | |
#6 | Macromolecular chemistry and polymers | |
#7 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Reduction of greenhouse gas emissions | |
#5 | Diagnosis and surgery | |
#6 | Analysing materials | |
#7 | Syringes | |
#8 | Pigments | |
#9 | Polysaccharides | |
#10 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Tamaru Yutaka | 5 |
#2 | Ishihara Atsushi | 2 |
#3 | Nishio Yuji | 2 |
#4 | Iwamoto Yasukazu | 2 |
#5 | Tsutsumi Hiroko | 2 |
#6 | Hashimoto Tadanori | 2 |
#7 | Akiyama Shin-Ichi | 1 |
#8 | Imanishi Nobuyuki | 1 |
#9 | Arai Tetsuya | 1 |
#10 | Okuda Seiji | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015147318A1 | Alcohol production method | |
WO2015122538A1 | Alcohol manufacturing method | |
EP2695938A1 | Antibody production method | |
CN103282767A | Ion-selective electrode | |
WO2011093098A1 | Novel indocyanine compound, synthesis method thereof, purification method thereof, diagnostic composition using indocyanine compound, and device for measuring in vivo kinetics and device for visualizing circulation using diagnostic composition | |
TW201042043A | Production method of transgenic goldfish and gene expression vector for the same |